Sam Lee

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

• Ionis Pharmaceuticals (United States)14.6%
• University of Oxford10.5%
• Johns Hopkins University8.9%
• Canada's Michael Smith Genome Sciences Centre8.6%
• Inserm7%
• Broad Institute6.4%
• Other43.9%

Fields

• Medicine49.7%
• Biochemistry, Genetics and Molecular Biology26.2%
• Computer Science10%
• Immunology and Microbiology3.2%
• Neuroscience3%
• Engineering2.1%
• Other5.9%

Topics

• COVID-19 Clinical Research Studies25.6%
• SARS-CoV-2 and COVID-19 Research15.7%
• Long-Term Effects of COVID-1912.5%
• Genomics and Phylogenetic Studies7.3%
• RNA and protein synthesis mechanisms5%
• RNA modifications and cancer4.3%
• Other29.6%